Investor Service Announcement no. 2/2007
Hørsholm, Denmark, 16 May 2007
LifeCycle Pharma To Present at BioEquity Europe 2007
Biotechnology Conference
Summary: LifeCycle Pharma to Present at BioEquity Europe 2007 Biotechnology
Conference
LifeCycle Pharma A/S (OMX:LCP) today announced that its President and CEO, Dr.
Flemming Ornskov, will be presenting a company update at the BioEquity Europe
2007 Biotechnology Conference on 22 May 2007 at 10:25 local time in room
Megalithic 1. The two-day conference is being held at the Radisson SAS Hotel in
Glasgow, Scotland. The conference will feature presentations from select
European companies.
For further information please contact:
LifeCycle Pharma A/S
Michael Wolff Jensen
Executive Vice President and CFO
Tel. +45 40 74 62 44
---oo0oo---
About LifeCycle Pharma A/S:
LifeCycle Pharma, headquartered in Hørsholm, Denmark, is an emerging
pharmaceutical company with a broad and late stage product pipeline in
therapeutic areas of cholesterol management, hypertension, organ transplant and
autoimmune diseases. LifeCycle Pharma's product candidates are proprietary and
designed to improve the quality of existing drugs by enhancing the release and
absorption of drugs in the human body. LifeCycle Pharma's proprietary technology
platform, MeltDose® technology, offers lower dosing, reduced side effects and
improved safety and patient compliance, as well as reduced product development
time and development costs. LifeCycle Pharma is listed on the OMX Nordic
Exchange under the trading symbol (LCP). Please visit www.lcpharma.com for
further information about LifeCycle Pharma A/S.
LifeCycle Pharma To Present at BioEquity Europe 2007 Biotechnology Conference
| Source: Veloxis Pharmaceuticals A/S
Attachments
